A phase II clinical trial (NCT01791985) involving patients with ER + breast cancer has been carried out to assess the therapeutic potential of AZD4547 when combined with letrozole or anastrozole, however, the results are not yet available. The gene discussed is ESR1; the disease is breast carcinoma.